2024-517539-38-00招募中1 期
Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 89
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Department
Scientific
Freya Biosciences ApS
研究点 (1)
Loading locations...
相似试验
招募中
2 期
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
(ADCElerate 1)2024-516900-41-00ADCendo ApS105
已完成
1 期
A phase 1/2a study to evaluate the dose, safety, tolerability, and efficacy of an intraperitoneal α-emitting radionuclide therapy (Radspherin®) in subjects with peritoneal carcinomatosis from colorectal carcinoma following hyperthermic intraperitoneal chemotherapy2024-511853-23-00Oncoinvent ASA54
已完成
1 期
An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects2023-504916-14-00Azafaros B.V.7
招募中
1 期
Phase 1, open-label, multicenter, dose escalation study of SRG-1505 as monotherapy in subjects with mature b-cell malignancies2023-505204-34-00Schrodinger Inc.22
已完成
1 期
A first in human single dose escalation study to investigate the safety, tolerability, pharmacokinetics, and pharmcodynamics of BAY 3389934 compared with placebo.2022-502866-25-00Bayer AG86